Infectious Disease in Urgent Care: A Practical Approach to Fever, Sepsis, Exposure, Testing, Isolation, and Antimicrobial Stewardship

The infectious-disease question is larger than “viral or bacterial?”

Urgent-care clinicians evaluate fever, respiratory illness, rash, diarrhea, urinary symptoms, wounds, bites, and sexually transmitted infections every day. The first question is not whether an antibiotic can be prescribed. The clinician must determine whether the patient is physiologically stable, identify a probable source, assess host vulnerability, recognize highly transmissible or reportable disease, and decide whether treatment is time-sensitive.

The same pathogen may cause mild disease in one patient and organ failure in another. Conversely, fever can arise from inflammatory disease, malignancy, thrombosis, medication reactions, heat illness, or endocrine emergencies. “Infection” should remain a working hypothesis until the clinical pattern supports it.

First decision: sepsis or another emergency?

Sepsis is life-threatening organ dysfunction caused by a dysregulated response to infection. It may begin from pulmonary, urinary, gastrointestinal, skin, or other sources and can progress rapidly.[1]

Obtain complete vital signs and assess mental status, perfusion, work of breathing, oxygenation, hydration, urine output, and general appearance. Repeat abnormal measurements. Emergency evaluation is generally indicated for:

• Hypotension, altered mental status, mottling, delayed capillary refill, weak pulses, or shock
• Respiratory distress, hypoxemia, cyanosis, or rapidly increasing oxygen requirement
• Marked tachypnea or persistent tachycardia with systemic illness
• Oliguria or anuria, severe dehydration, or inability to tolerate fluids
• Toxic appearance, extreme pain, rapidly progressive infection, or concern for necrotizing disease
• Meningismus, seizure, focal neurologic deficit, severe headache, or petechial/purpuric rash with systemic illness
• Suspected infected obstruction, deep-space infection, endocarditis, epidural abscess, septic arthritis, or other source requiring drainage or procedural control
• Fever in a patient with severe neutropenia, recent transplant, major immune suppression, or other high-risk state
• Young infant with fever requiring age-specific emergency evaluation
• Suspected severe malaria, enteric fever, viral hemorrhagic fever, or other serious travel-associated infection

No outpatient score replaces clinical judgment. A normal lactate, normal white count, or absence of fever does not exclude sepsis, particularly early or in immunocompromised and older patients.

Build the assessment from three axes

1. Syndrome and source

Identify the dominant syndrome: respiratory, neurologic, gastrointestinal, urinary, skin or soft tissue, bone or joint, bloodstream, genital, or fever without an obvious source. Examine beyond the patient’s assumed diagnosis. A person requesting “UTI antibiotics” may have pyelonephritis or pelvic inflammatory disease; a “flu” presentation may be pneumonia, meningitis, or diabetic ketoacidosis.

2. Host risk

Ask about age extremes, pregnancy, diabetes, chronic lung, heart, kidney, or liver disease, anatomic abnormalities, malignancy, HIV, neutropenia, asplenia, transplant, immune-modifying drugs, indwelling devices, recent surgery, and prior resistant organisms. Review vaccination status relevant to the syndrome.

3. Epidemiology and exposure

Ask about sick contacts, travel, residence, occupation, healthcare exposure, institutional living, outbreaks, animals, insects and ticks, food and water, sexual practices, injection drug use, wounds, water exposure, and recent antibiotics. The place, season, incubation period, and cluster may be more diagnostic than one symptom.

Focused history

Establish onset, maximum temperature and method, fever pattern, antipyretic use, progression, and associated rigors, sweats, fatigue, weight loss, or night sweats. Ask whether symptoms improved and then worsened, suggesting a complication or secondary process.

Review source-specific symptoms: cough, dyspnea, sore throat, headache, neck stiffness, rash, abdominal pain, vomiting, diarrhea, dysuria, flank pain, wound drainage, joint pain, and genital lesions. Determine oral tolerance and urine output.

Create a medication timeline. Antibiotics can change cultures, cause diarrhea or drug eruptions, interact with other drugs, and select resistant organisms. Steroids may blunt fever and worsen certain infections. Ask about over-the-counter antipyretics to prevent duplicate acetaminophen dosing.

Focused examination

Do not let a positive rapid test truncate the examination. Assess airway, lungs, heart, abdomen, flanks, skin, wounds, joints, neurologic status, and hydration as indicated. Inspect devices and procedure sites. Look for petechiae, purpura, vesicles, eschar, lymphangitis, jaundice, oral lesions, and mucosal involvement.

For fever without an obvious source, perform a head-to-toe source search while respecting privacy. Recheck areas that can hide infection: oral cavity and teeth, ears, skin folds, perineum, feet, pressure areas, catheter sites, and recent wounds.

Respiratory viral infections

Influenza, COVID-19, RSV, and other viruses have substantial symptom overlap. Testing decisions should consider local activity, host risk, treatment eligibility, infection control, and whether the result will alter care.

For higher-risk outpatients with suspected influenza or COVID-19, antiviral treatment is time-sensitive. CDC guidance states that treatment may begin on clinical judgment without waiting for a positive result when suspicion and risk support it. Influenza benefit is greatest when treatment begins early, ideally within two days, but high-risk or progressive illness may warrant treatment later. Eligible COVID-19 therapy must begin within the product-specific early treatment window.[2]

Before prescribing a COVID-19 antiviral, review renal and hepatic function, pregnancy considerations, interacting drugs, and whether medications must be held or adjusted. For influenza agents, review age, pregnancy, renal function, inhaled-drug contraindications, and local susceptibility guidance.

A positive viral test does not exclude bacterial pneumonia, sepsis, asthma exacerbation, pulmonary embolism, or co-infection. Escalate patients with hypoxemia, respiratory distress, chest pain, confusion, dehydration, or clinical deterioration.

Fever with rash and highly transmissible disease

Rash morphology, distribution, mucosal findings, medication timing, vaccination, and exposure history matter. Fever plus petechiae or purpura, skin pain, blistering, mucosal erosion, hypotension, or toxicity requires emergency evaluation.

Measles should be considered with fever, cough, coryza, conjunctivitis, and a descending maculopapular rash, especially after exposure, travel, or uncertain vaccination. Suspected patients should not sit in a common waiting area. CDC recommends immediate airborne isolation, notification of infection-control personnel and public health, and laboratory confirmation.[3]

Do not send a potentially measles-infected patient unannounced to another facility. Coordinate arrival so airborne precautions can be prepared. Similar advance coordination may be required for other high-consequence airborne or emerging infections.

Fever without a clear source

The differential includes early localized infection, bacteremia, endocarditis, occult abscess, tuberculosis, travel-related infection, medication fever, inflammatory disease, malignancy, thromboembolism, thyroid storm, adrenal crisis, and heat illness.

Persistent fever, weight loss, night sweats, new murmur, embolic findings, injection drug use, prosthetic valve, indwelling vascular device, recent procedure, or positive blood cultures should raise concern for endocarditis. Routine outpatient oral antibiotics can sterilize cultures and delay diagnosis; arrange hospital evaluation when the pattern is concerning.

High-risk hosts

Immunocompromised patients

The absence of impressive local inflammation does not reassure in neutropenia or major immune suppression. Fever may be the only sign of a life-threatening infection. Clarify the immune condition, medication, most recent neutrophil count when known, transplant status, prophylaxis, and treating specialty. Suspected febrile neutropenia requires immediate emergency evaluation and rapid empiric intravenous therapy—not routine outpatient culture follow-up.

Asplenia

Asplenic patients are vulnerable to rapidly progressive infection from encapsulated organisms. Fever with systemic symptoms warrants a low threshold for immediate parenteral antibiotics and emergency evaluation according to the patient’s established plan and current guidance.

Pregnancy

Pregnancy changes risk, diagnostic options, medication selection, and thresholds for escalation. Influenza and COVID-19 can be more severe in pregnancy; recommended treatment should not be withheld solely because of pregnancy when benefits outweigh risks.[4] Consider obstetric sources and fetal well-being based on gestation and symptoms.

Older adults and infants

Older adults may present with weakness, falls, decreased intake, or confusion rather than high fever. Avoid labeling nonspecific delirium as UTI based only on bacteriuria; search for alternate causes.

Young infants require age-specific fever pathways because serious bacterial infection may present subtly. Urgent-care capability and reliable measurement of age, temperature, appearance, and follow-up determine disposition; many febrile young infants require emergency evaluation.

Testing: order it to change a decision

• Respiratory antigen or molecular tests: Use when treatment, isolation, prognosis, or public health changes.
• Urinalysis and culture: Interpret with urinary symptoms and host context; pyuria or bacteriuria alone does not prove symptomatic UTI.
• Strep testing: Test the appropriate pharyngitis population rather than treating exudate alone.
• Stool testing: Reserve for inflammatory, severe, prolonged, outbreak-associated, travel-related, or high-risk disease.
• NAAT for STIs: Match specimen sites to anatomy and exposure.
• CBC and metabolic testing: Useful for severity, cytopenia, organ dysfunction, or medication safety but rarely identifies the pathogen alone.
• Blood cultures: Obtain before antibiotics when bacteremia, sepsis, endocarditis, enteric fever, or severe immune compromise is suspected, without delaying emergency treatment.
• Imaging: Search for pneumonia, obstruction, abscess, osteomyelitis, septic joint, or another source when clinical findings require it.

Understand test limitations. Antigen sensitivity varies with timing and specimen quality; molecular tests may detect residual nucleic acid; colonization can be mistaken for infection; and a negative early test may not eliminate a high-probability disease.

Antimicrobial stewardship

Stewardship means giving effective treatment promptly when it is needed and avoiding antibiotics when they offer no benefit. Before prescribing, document:

• The anatomic syndrome and evidence supporting bacterial infection
• Likely organisms and whether source control is required
• Allergy phenotype rather than “allergic” alone
• Pregnancy, renal and hepatic function, interactions, and recent antibiotics
• Prior cultures and local resistance
• Dose, route, duration, expected response, and follow-up plan

Prefer the narrowest effective agent and shortest evidence-based course. Do not use an antibiotic to satisfy uncertainty when imaging, drainage, culture, or escalation is the actual need. Antibiotics can cause allergic reactions, organ toxicity, interactions, C. difficile infection, and resistance.[5]

Source control

Abscess, empyema, infected obstruction, septic joint, necrotic tissue, infected device, and some deep-space infections require drainage, removal, or surgery. Antibiotics alone may fail even if the organism is susceptible.

Culture follow-through

A culture is not complete when the specimen is collected. Establish responsibility for reviewing results, contacting the patient, changing or stopping therapy, addressing resistance, and documenting the communication. Culture improvement does not override clinical deterioration.

Isolation, reporting, and occupational considerations

Use standard precautions for every patient and transmission-based precautions according to the suspected pathogen. Place a mask on a symptomatic respiratory patient when appropriate, separate contagious patients promptly, and clean shared equipment.

Know how to contact the local health department. Suspected measles, meningococcal disease, certain foodborne infections, tuberculosis, and other conditions may require immediate reporting, coordinated testing, prophylaxis of contacts, or workplace restrictions. Requirements vary by jurisdiction.

Ask whether the patient works in healthcare, food service, childcare, long-term care, or another high-risk setting. A generic work note may be unsafe if public-health exclusion criteria apply.

Common diagnostic traps

• “The fever is too high to be viral.” Temperature magnitude alone does not identify etiology.
• “The mucus is green, so antibiotics are needed.” Color does not establish bacterial infection.
• “The rapid test is positive, so that explains everything.” Coincidental positivity and complications still occur.
• “The white count is normal, so sepsis is excluded.” Early and immune-compromised infections may lack leukocytosis.
• “They improved after ceftriaxone.” Short-term improvement does not prove the diagnosis or guarantee adequate therapy.
• “The culture grew bacteria, so symptoms are infection.” Colonization and contamination require clinical interpretation.
• “No fever means no infection.” Older age, immune suppression, medications, and early disease may blunt fever.

Symptomatic treatment safeguards

Antipyretics improve comfort but do not treat the source. Review total daily acetaminophen from combination products, liver disease, alcohol use, NSAID-related renal and GI risks, pregnancy, dehydration, and age-based dosing.

Systemic corticosteroids should not be used as a nonspecific treatment for undifferentiated fever or viral symptoms. They can worsen glycemia, suppress immune responses, and obscure progression. Use them only for a defined indication with a risk-benefit assessment.

Avoid sedating cough or nausea combinations when respiratory status, driving, older age, or interacting medications create risk. In children, verify age restrictions and weight-based calculations.

Disposition and follow-up

Outpatient care requires physiologic stability, a plausible low-risk syndrome, adequate hydration and oral tolerance, feasible treatment, and reliable follow-up. High-risk hosts deserve a lower threshold for escalation and earlier reassessment.

Provide exact emergency precautions: breathing difficulty, chest pain, confusion, fainting, severe headache, stiff neck, seizure, nonblanching rash, rapidly spreading redness, severe or disproportionate pain, reduced urine, persistent vomiting, dehydration, new jaundice, or worsening after initial improvement.

State the expected trajectory. Many uncomplicated viral illnesses peak over several days and improve gradually. Fever that persists, returns after improvement, or accompanies a new focal symptom warrants reassessment. A patient started on antibacterial therapy should generally show meaningful clinical improvement within the diagnosis-specific interval; failure requires reconsideration of resistance, adherence, source control, complication, or incorrect diagnosis.

Documentation that supports safe care

Document illness timeline, measured fever, exposures, travel, vaccination, immune status, devices, recent antibiotics, prior resistance, pregnancy, and occupation. Record complete vital signs, appearance, perfusion, hydration, respiratory and neurologic status, source-specific findings, and repeat assessments.

State important emergency diagnoses considered, test limitations, treatment eligibility windows, medication interaction review, infection-control actions, public-health communication, culture ownership, disposition rationale, and specific return precautions.

Example medical-decision-making language

Patient is clinically stable, well perfused, alert, and tolerating oral fluids without hypoxemia, respiratory distress, meningismus, altered mental status, nonblanching rash, focal severe pain, or evidence of organ dysfunction. Current history and examination support an uncomplicated acute viral syndrome. Pneumonia, sepsis, meningitis, deep infection, and other focal bacterial sources were considered but are not supported by the current evaluation. Antibiotics are not indicated. Treatment eligibility for influenza and COVID-19 was assessed based on symptom timing and risk. Follow-up and emergency precautions were reviewed for breathing difficulty, confusion, dehydration, persistent or recurrent fever, new focal symptoms, or clinical deterioration.

Adapt this language to the encounter and never document findings that were not assessed.

Coding considerations

Common ICD-10-CM examples include:

• R50.9 — Fever, unspecified
• B34.9 — Viral infection, unspecified
• J06.9 — Acute upper respiratory infection, unspecified
• U07.1 — COVID-19
• J10.1 — Influenza with other respiratory manifestations, seasonal influenza virus identified
• Z20.828 — Contact with and suspected exposure to other viral communicable diseases
• A41.9 — Sepsis, unspecified organism

Use confirmed organism, syndrome, complications, exposure versus active disease, and encounter-specific codes when supported. Do not code sepsis merely because it was considered or use “viral infection” when a more accurate diagnosis is established. Verify the current code set.

Potential CPT reporting may include evaluation-and-management services, respiratory testing, strep testing, urinalysis, cultures, blood tests, imaging, injections, hydration, and procedures actually performed. Verify medical necessity, test complexity, supervision, bundling, and payer rules.

Clinical pearls

• Infection severity is a host-pathogen interaction, not a temperature number.
• Source, host, and exposure are the three core axes.
• Sepsis may occur without fever or leukocytosis.
• A positive rapid test does not end the examination.
• Antivirals are time-sensitive; assess eligibility early.
• Suspected measles belongs in airborne isolation, not the waiting room.
• Febrile neutropenia is an emergency.
• Antibiotics cannot drain an abscess or decompress an infected kidney.
• Treat the patient, not colonization or a contaminated specimen.
• Culture follow-up requires named ownership.
• Steroids can conceal infection progression.
• Public-health coordination is part of clinical care.
• When the diagnosis is uncertain, safe disposition is more valuable than false specificity.

Conclusion

Infectious-disease care in urgent care is a structured exercise in risk. Identify instability and sepsis first, then define the syndrome, host vulnerability, and epidemiologic context. Use testing to change decisions, isolate before exposure occurs, start time-sensitive antivirals promptly, and reserve antibacterial treatment for presentations where benefit is likely.

The clinician’s responsibility continues after the prescription: source control, culture review, partner or contact management, public-health reporting, and explicit reassessment all determine whether treatment succeeds. When infection threatens organ function or requires hospital diagnostics, intravenous therapy, drainage, or airway support, timely escalation is the definitive urgent-care intervention.

References

1. Centers for Disease Control and Prevention. About sepsis [Internet]. Atlanta: CDC; 2026 Mar 23 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/sepsis/about/index.html
2. Centers for Disease Control and Prevention. Clinical guidance for outpatients with acute respiratory illness at higher risk of severe COVID-19 and/or influenza [Internet]. Atlanta: CDC; 2025 Dec 19 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/flu/hcp/clinical-guidance/testing-guidance-for-outpatient.html
3. Centers for Disease Control and Prevention. Clinical overview of measles [Internet]. Atlanta: CDC; 2026 Mar 3 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/measles/hcp/clinical-overview/index.html
4. Centers for Disease Control and Prevention. People at increased risk for severe respiratory illnesses [Internet]. Atlanta: CDC; 2025 Aug 18 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/respiratory-viruses/risk-factors/index.html
5. Centers for Disease Control and Prevention. Manage common cold [Internet]. Atlanta: CDC; 2026 Mar 11 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/common-cold/treatment/index.html